Strides Pharma Science is investing in SteriScience Pharma (SteriScience) to make it the company’s dedicated arm for global sterile injectables business. SteriScience has started the development activity for 20 plus quick to launch products and expects the first Abbreviated New Drug Application (ANDA) filing to be achieved within FY21. Furthermore, SteriScience has entered into a Joint Venture (JV) with Brooks Laboratories (Brooks) for building a robust carbapenem business with integrated manufacturing capabilities. The transaction with Brooks is subject to approval from the shareholders of Brooks.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
